Neuronetics Prepares for Q4 Earnings and Highlights Progress
Neuronetics Plans to Reveal Q4 2024 Results
Neuronetics, Inc., a pioneering company in medical technology, dedicated to enhancing patient quality of life amidst neurohealth disorders, is set to announce its fourth quarter 2024 financial and operational results. The announcement is scheduled prior to market opening on an upcoming Tuesday. Following this release, the company will also host a conference call aimed at reviewing these results, with the call set to commence at 8:30 a.m. Eastern Time.
Details of the Upcoming Conference Call
The conference call is expected to attract significant attention and will be available for live listening via webcast. Participants can access the call through a dedicated link. Although advanced registration is not mandatory, attendees are encouraged to join approximately ten minutes before the scheduled start time.
About Neuronetics: A Leader in Mental Health Solutions
Neuronetics truly understands the importance of mental health, viewing it on par with physical health. As a leader in the field of neuroscience, the company is reshaping the landscape of mental health treatment with its innovative NeuroStar Advanced Therapy. This non-invasive, non-pharmaceutical treatment option aims to dramatically improve the lives of individuals battling neurohealth issues, especially when conventional medications fall short. NeuroStar has shown significant effectiveness in treating major depressive disorder (MDD) and is available as a secondary treatment for anxiety symptoms in adults who experience MDD.
Significance of NeuroStar Advanced Therapy
Having administered over 6.9 million treatments, NeuroStar stands as a dominant name in transcranial magnetic stimulation (TMS) therapy. This treatment is not only cleared by the FDA for use in adults with MDD but is also approved for adolescents aged between 15 to 21. With the unrivaled success that NeuroStar has had in transforming numerous lives, Neuronetics remains committed to delivering exceptional healthcare and innovative treatments that cater to individual needs.
Investor Relations and Company Commitment
Neuronetics prides itself on maintaining transparent communication with its investors. Should you need to get in touch with their investor relations team, reach out to Mike Vallie or Mark Klausner at ICR Healthcare. The team is readily available to address any questions or provide further insights regarding the company's performance and future outlook. You may contact them at 443-213-0499 or via email at ir@neuronetics.com.
Media Inquiries
For media-related inquiries or further information, representatives from EvolveMKD are tasked with handling communications. Their dedicated media contact can be reached at 646-517-4220 or via email at NeuroStar@evolvemkd.com.
Frequently Asked Questions
What is the purpose of the upcoming conference call?
The conference call will provide an overview of Neuronetics' financial performance and operational results for the fourth quarter of 2024.
How does NeuroStar Advanced Therapy work?
NeuroStar is a non-invasive treatment that utilizes TMS to alleviate symptoms of major depressive disorder and anxiety in patients.
Who can benefit from NeuroStar treatment?
Adults suffering from MDD who have not found relief from traditional medication, as well as adolescents aged 15 to 21 with MDD, can benefit from NeuroStar.
How can investors contact Neuronetics?
Investors can contact Mike Vallie or Mark Klausner at ICR Healthcare for inquiries or assistance regarding the company's progress.
Who should media inquiries be directed to?
All media inquiries should be directed to EvolveMKD, specifically the contact person at 646-517-4220 or via email.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
